Business Context and Reporting Period
Company: Disc Medicine, Inc. (Nasdaq: IRON)
Filing Type: Form 8-K (Current Report)
Date of Report: December 8, 2024
Event: The Company held a conference call and webcast to review data presented at the 66th American Society of Hematology (ASH) Annual Meeting and Exposition, along with operational plans. A slide presentation from this event is attached as Exhibit 99.1.
Financial Metrics
This filing is a Current Report on Form 8-K regarding a corporate event and does not contain financial statements. Consequently, the filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
No material financial changes versus a prior comparable period are reported in this document. The filing focuses solely on the dissemination of clinical data and operational updates.
Guidance, Outlook, and Risks
- Management Commentary: The Company discussed data from the ASH Annual Meeting and its operational plans during the conference call.
- Forward-Looking Statements: The Company explicitly states it undertakes no obligation to update, supplement, or amend the materials attached as Exhibit 99.1.
- Risks and Contingencies: No specific risks or contingencies are detailed in the body of this 8-K filing.
Key Facts for Investor Verification
- Verify the specific clinical data and results presented at the 66th ASH Annual Meeting by reviewing Exhibit 99.1 (the attached slide presentation).
- Confirm the Company's operational plans as outlined in the December 8, 2024, conference call.
- Note that this filing does not include updated financial metrics; investors should refer to the most recent 10-K or 10-Q for financial status.